Publishing and Submission of a grouped application of Type IAIN Variations (IA-Supergroup)

Case study - 15 October 2020

BlueReg Group Case study Publishing and Submission of a grouped application of Type IAIN Variations (IA-Supergroup)

Publishing and Submission of a grouped application of Type IAIN Variations (IA-Supergroup)

A global specialty-driven biopharmaceutical group focused on innovation and specialty care entrusted BlueReg to co-ordinate the publishing and submission of a grouped application of Type
IAIN variations. This impacted several different products from the same Marketing Authorisation Holder, with different Reference Member States (IA Supergroup).

In parallel, to publish and submit the same variation dossiers as a grouped application of Type IAIN variations for nationally registered products.

    Dowload The Case Study


    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more


    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to:

    GDPR data request


    Thank you for your reply

    The file will be sent to you by email.

    Download

    Contact our experts today

    Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any area of product development, commercialisation and early access programs, and life cycle management

    Make an enquiry